Delivery Order SPE2DB22D3301-SPE2DB25FY0CD

Award Date 2/14/25
Potential Completion Date 3/10/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,819.01 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, with an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $5,624.62, is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,996.96, is a Firm Fixed Price Delivery Order for the supply of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $5,624.62, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product TASIGNA 150 MG CAPSULE 28S, with an ultimate completion date of May 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $11,638.02 firm fixed-price delivery order contract is for the supply of the medication Tasigna (150 mg capsules), with a period of performance through January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The firm-fixed-price contract has a ceiling value of $5,624.62 and an ultimate completion date of November 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $5,624.62 for the supply of TASIGNA 150 MG CAPSULE 28S medication. The contract has an Ultimate Completion Date of July 24, 2024 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $11,638.02 firm-fixed-price contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a specialty medication. The contract has an ultimate completion date of January 7, 2025 and was awarded on December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025, and it is not designated as a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY0CD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,638.02, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 10, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:22 PM